홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

디클로로페나마이드

Dichlorphenamide

HCID 3038
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
120-97-8
표준 SMILES
NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1
InChIKey
GJQPMPFPNINLKP-UHFFFAOYSA-N
분자식
C6H6Cl2N2O4S2
평균 분자량
305.2 g/mol
단동위원소 질량
303.9146044

개요

Dichlorphenamide can cause developmental toxicity according to state or federal government labeling requirements.

이름 및 식별자

우선 이름
Dichlorphenamide
IUPAC
4,5-dichlorobenzene-1,3-disulfonamide
현지명
디클로로페나마이드
영어명
Dichlorphenamide
분자식
C6H6Cl2N2O4S2
분자량
305.16

이름 및 동의어

dichlorphenamideDiclofenamide120-97-84,5-dichlorobenzene-1,3-disulfonamideDichlorophenamideDichlofenamideDaranideAntidrasiGlaucolOratrol1,3-Benzenedisulfonamide, 4,5-dichloro-Dichlorphenamid
이름 더 보기
디클로로페나마이드디클로로페나미드cb8000CB 8000GlaucorOralconDalanidedaramide
DiclofenamidDiclofenamidaDiclofenamidum4,5-Dichloro-m-benzenedisulfonamide1,3-Disulfamyl-4,5-dichlorobenzene1,3-Disulfamoyl-4,5-dichlorobenzene4,5-Dichloro-1,3-disulfamoylbenzeneKeveyis

데이터베이스 식별자

CAS
120-97-8
PubChem CID
3038
DTXSID
DTXSID1022922
ChEMBL
CHEMBL17
ChEBI
CHEBI:101085
UNII
VVJ6673MHY
EC Number
204-440-6
Nikkaji
J8.589H

물성

구조 계산 물성보충 중

XLogP
0.3
극성 표면적
137 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
6
회전 가능 결합 수
2
무거운 원자 수
16
형식 전하
0
복잡도
452

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
LogP · 2건

0.2

0.92

OdorSLIGHT CHARACTERISTIC ODOR
Color/Form · 2건

NEEDLES FROM DIMETHYLSULFOXIDE + WATER

WHITE OR NEARLY WHITE, CRYSTALLINE POWDER

Solubility · 3건

PRACTICALLY INSOL IN WATER; SOL IN ALKALINE SOLN

FREELY SOL IN PYRIDINE & IN 1 N NAOH; SOL IN ALCOHOL; SOL IN 2 N SODIUM CARBONATE; SLIGHTLY SOL IN ETHER

3.98e-01 g/L

Human Drugs · 3건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Melting Point · 2건

239-241 °C

228.7 °C

Physical DescriptionSolid
Dissociation ConstantsPKA: 7.4, KA: 8.6

물리화학적 성질

녹는점
239 · 239-241° (patent, mp 228.5-229°)
끓는 점
590.5 · 590.5±60.0 °C(Predicted)
밀도
1.7263 · 1.7263 (rough estimate)
굴절률
1.6 · 1.6000 (estimate)
저장 조건
Sealed in dry,Room Temperature
용해도
아세토니트릴(약간 용해됨), 클로로포름, DMSO(약간 용해됨), 메탄올에 용해됨
물리적 상태
고체
산도 계수 (pKa)
7.4 · pKa 7.4 (Uncertain);8.6 (Uncertain)
색상
흰색에서 황백색까지
주요 응용
의약품(소분자)
InChI
InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)
InChIKey
GJQPMPFPNINLKP-UHFFFAOYSA-N
SMILES
C1(S(N)(=O)=O)=CC(Cl)=C(Cl)C(S(N)(=O)=O)=C1
NIST
4 · 4,5-Dichloro-m-benzenedisulfonamide(120-97-8)
EPA
1 · 1,3-Benzenedisulfonamide, 4,5-dichloro- (120-97-8)

화학적 성질

Off-White Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P264, P264+P265, P280, P302+P352, P305+P351+P338, P318, P321, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 2건

Hazard Traits - Developmental Toxicity

1,3-Benzenedisulfonamide, 4,5-dichloro-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - 1,3-Benzenedisulfonamide, 4,5-dichloro-: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (50%)

독성 정보

Human Toxicity Excerpts · 5건

CALCULUS FORMATION & URETERAL COLIC HAVE BEEN ATTRIBUTED TO MARKED REDN IN URINARY CITRATE...ASSOC WITH EITHER NO CHANGE OR EVEN RISE IN URINARY CALCIUM. ...DEPRESSES UPTAKE OF IODINE BY THYROID GLAND. /ACETAZOLAMIDE/

WITH LARGE DOSES, MANY PT EXHIBIT DROWSINESS & PARESTHESIAS. IN HEPATIC CIRRHOSIS, EPISODES OF DISORIENTATION MAY BE INDUCED. ... HYPERSENSITIVITY REACTIONS ARE RELATIVELY RARE. THEY CONSIST IN FEVER, SKIN REACTIONS, BONE-MARROW DEPRESSION, & SULFONAMIDE-LIKE RENAL LESIONS. /CARBONIC ANHYDRASE INHIBITORS/

LESS FREQUENT UNTOWARD REACTIONS INCL FATIGUE, EXCITEMENT, & GI REACTIONS. /CARBONIC ANHYDRASE INHIBITORS/

GI DISTURBANCES...ANOREXIA, NAUSEA, VOMITING, DIARRHEA, WT LOSS, ALTERED TASTE & SMELL, CONSTIPATION, DRYNESS OF MOUTH, EXCESSIVE THIRST...ABDOMINAL DISTENTION...PARESTHESIA...NUMBNESS & TINGLING SENSATION...IN EXTREMITIES, TONGUE, &/OR MUCOCUTANEOUS JUNCTIONS OF LIPS OR ANUS /ADVERSE EFFECT, ORAL/

For more Human Toxicity Excerpts (Complete) data for DICHLORPHENAMIDE (6 total), please visit the HSDB record page.

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Dichlorphenamide

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Non-Human Toxicity ExcerptsANIMAL STUDIES INDICATE SOME TERATOGENIC EFFECTS...

안전 데이터

wgk
WGK 3
rtecs
CZ9200000
HS 번호
2935904000
risk_code
63
hazard_code
Xn
safety_code
36
기존화학 물질
KE-10069
스토리지 클래스
11 - Combustible Solids
유해 물질 데이터
120-97-8(Hazardous Substances Data)

화학 및 산업

약리 정보

ATC Code · 2건

S - Sensory organs

QS - Sensory organs

Protein Binding55%
Pharmacodynamics · 1건

Dichlorphenamide is an oral carbonic anhydrase inhibitor indicated for adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Carbonic anhydrase inhibitors reduce intraocular pressure by partially suppressing the secretion of aqueous humor (inflow).

Mechanism of Action · 6건

Carbonic anhydrase inhibitors reduce intraocular pressure by partially suppressing the secretion of aqueous humor (inflow), although the mechanism by which they do this is not fully understood. Evidence suggests that HCO<sup>3-</sup> ions are produced in the ciliary body by hydration of carbon dioxide under the influence of carbonic anhydrase and diffuse into the posterior chamber which contains more Na<sup>+</sup> and HCO<sup>3-</sup> ions than does plasma and consequently is hypertonic. Water is then attracted to the posterior chamber by osmosis, resulting in a drop in pressure.

PHOSPHATURIA MAY BE RELATED TO DIRECT STIMULATION...OF CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE...PRODN BY KIDNEY. ...DRUG ACTS SIMILARLY TO PARATHYROID HORMONE IN ENHANCING URINARY EXCRETION OF PHOSPHATE & CYCLIC AMP, IN CONTRAST TO ITS ANTAGONISM OF ACTION OF HORMONE ON BONE. /ACETAZOLAMIDE/

...INHIBITION OF...CARBONIC ANHYDRASE. ...IS NONCOMPETITIVE. ...ENZYME IS NORMALLY PRESENT IN TISSUES IN HUGE EXCESS. MORE THAN 99% OF ENZYME ACTIVITY IN KIDNEY MUST BE INHIBITED BEFORE PHYSIOLOGICAL EFFECTS BECOME APPARENT. ENZYME...IS DOMINANT TISSUE COMPONENT TO WHICH INHIBITORS BECOME BOUND. /ACETAZOLAMIDE/

/CHANGES IN URINE/...MAY BE ATTRIBUTED TO INHIBITION OF (+)H SECRETION BY RENAL TUBULE. ... CURRENT EVIDENCE INDICATES GREATER EFFECT ON PROXIMAL THAN ON DISTAL TUBULE, WITH LITTLE OR NO EFFECT ON ASCENDING LIMB. ...PHOSPHATURIA...USED AS INDEX OF LOCALIZING DIURETIC ACTION... /ACETAZOLAMIDE/

...INCR URINARY EXCRETION OF BICARBONATE & FIXED CATION, MOSTLY SODIUM. AS RESULT, CONCN OF BICARBONATE IN EXTRACELLULAR FLUID DECR & METABOLIC ACIDOSIS RESULTS. ...RENAL RESPONSE TO ACETAZOLAMIDE IS GREATLY REDUCED.../BUT/ DIURETIC RESPONSE IS ENHANCED. /ACETAZOLAMIDE/

DRUG LOWERS INTRAOCULAR PRESSURE BY REDUCING RATE OF SECRETION OF AQ HUMOR.

FDA Pharmacological Classification · 6건

VVJ6673MHY

DICHLORPHENAMIDE

Established Pharmacologic Class [EPC] - Carbonic Anhydrase Inhibitor

Mechanisms of Action [MoA] - Carbonic Anhydrase Inhibitors

Chemical Structure [CS] - Sulfonamides

Dichlorphenamide is a Carbonic Anhydrase Inhibitor. The mechanism of action of dichlorphenamide is as a Carbonic Anhydrase Inhibitor.

MeSH Pharmacological ClassificationA class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.
Cellular LocationsCytoplasm

용도 및 제조

UsesMEDICATION
Methods of ManufacturingSCHULTZ, US PATENT 2,835,702 (1958 TO MERCK & CO).
Formulations/PreparationsDICHLORPHENAMIDE, USP (DARANIDE), IS AVAIL AS OFFICIAL 50-MG TABLETS.
Use ClassificationPharmaceuticals
응용 분야 · 1건

용도Like the drugs described above, dichlorphenamide is used for secreting excess water in cases of elevated intraocular pressure, and it is used for treating wide-angle and secondary glaucoma as well as in cases where it is necessary to lower intraocular pressure before surgical intervention in severe wide-angle glaucoma.

상·하류 제품 정보

상류 원료

1,2-디클로로벤젠암모니아(가스)인 펜타염화물클로로술폰산O-클로로페놀
추가 설명 · 1건

정의ChEBI: A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraoc lar pressure. It is used for the treatment of glaucoma.

관련 반응

2건
반응 기록 만들기
HRID 348779 반응식
HRID 348779반응물로
HRID 1903721 반응식
HRID 1903721반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트